Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by an autosomal dominant variant in the IMPG1 gene.
Biomarker and diagnostic research for IMPG1-related dominant retinopathy has been reported in the published literature.
No clinical trials have been registered for IMPG1-related dominant retinopathy.
235 publications have been identified in PubMed for IMPG1-related dominant retinopathy. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (17%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 88 | 37% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Common questions about IMPG1-related dominant retinopathy
Research summaries
40 |
17% |
Disease patterns and progression | 35 | 15% |
Patient case studies | 33 | 14% |
Testing and diagnosis research | 15 | 6% |
New treatment approaches | 14 | 6% |
Clinical study results | 9 | 4% |
Other research | 1 | 0% |
Gong X (2026). [PMID: 41497268](https://pubmed.ncbi.nlm.nih.gov/41497268/). *PeerJ*. [Review / Meta-Analysis]
Wada I (2026). [PMID: 42132459](https://pubmed.ncbi.nlm.nih.gov/42132459/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Gu X (2026). [PMID: 41529083](https://pubmed.ncbi.nlm.nih.gov/41529083/). *Ophthalmic Surg Lasers Imaging Retina*. [Epidemiology / Natural History]
Haddadzadegan S (2026). [PMID: 41865892](https://pubmed.ncbi.nlm.nih.gov/41865892/). *J Control Release*. [Review / Meta-Analysis]
Itabashi T (2026). [PMID: 42079405](https://pubmed.ncbi.nlm.nih.gov/42079405/). *Fujita Med J*. [Review / Meta-Analysis]
Han J (2026). [PMID: 41877771](https://pubmed.ncbi.nlm.nih.gov/41877771/). *Front Med (Lausanne)*. [Review / Meta-Analysis]
Cueva Vargas JL (2026). [PMID: 40994007](https://pubmed.ncbi.nlm.nih.gov/40994007/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Basic Science / Preclinical]
Cao B (2026). [PMID: 41617017](https://pubmed.ncbi.nlm.nih.gov/41617017/). *J Control Release*. [Basic Science / Preclinical]
Preiss D (2026). [PMID: 42117585](https://pubmed.ncbi.nlm.nih.gov/42117585/). *Health Technol Assess*. [Clinical Trial Publication]
Kung WM (2026). [PMID: 42248491](https://pubmed.ncbi.nlm.nih.gov/42248491/). *Exp Gerontol*. [Review / Meta-Analysis]